Thiazides are recommended first line agents for the treatment of hypertension. They have been demonstrated to lower cardiovascular disease. Which thiazide to choose has been a long-standing issue.

In this interview, Areef Ishani MD, MS and W. Douglas Weaver MD, MACC discuss AHA Late-Breaker: DCP – Chlorthalidone Compared to Hydrochlorothiazide for the Prevention of Cardiovascular Events in Patients with Hypertension.

Clinical Topics: Prevention, Statins, Hypertension, Pulmonary Hypertension and Venous Thromboembolism

Keywords: ACCELLite, Hypertension, Chlorthalidone, Hydrochlorothiazide

< Back to Listings